GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sansure Biotech Inc (SHSE:688289) » Definitions » Cash Flow for Lease Financing

Sansure Biotech (SHSE:688289) Cash Flow for Lease Financing : ¥0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Sansure Biotech Cash Flow for Lease Financing?

Sansure Biotech's Cash Flow for Lease Financing for the three months ended in Mar. 2024 was ¥0 Mil. Sansure Biotech's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0 Mil.

Compared with last quarter (¥0 Mil in Dec. 2023 ), Sansure Biotech's Cash Flow for Lease Financing remained the same in Mar. 2024 (¥0 Mil).

Sansure Biotech Cash Flow for Lease Financing Historical Data

The historical data trend for Sansure Biotech's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sansure Biotech Cash Flow for Lease Financing Chart

Sansure Biotech Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow for Lease Financing
Get a 7-Day Free Trial - - - - -

Sansure Biotech Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Sansure Biotech Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sansure Biotech Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Sansure Biotech's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Sansure Biotech (SHSE:688289) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sansure Biotech Inc (SHSE:688289) » Definitions » Cash Flow for Lease Financing
Comparable Companies
SZSE:301101 SHSE:688677 SZSE:002382 SHSE:603301 SHSE:688410 SZSE:301367 SZSE:300358 SHSE:688151 SHSE:605369 SZSE:002950 ISRG XPAR:EL BDX XSWX:ALC TSE:7741 WST OCSE:COLO B RMD TSE:4543 XSWX:STMN
Traded in Other Exchanges
N/A
Address
No. 680, Lusong Road, Changsha High-tech Industrial Development Zone, Hunan Province, Changsha, CHN, 410205
Website
http://www.sansure.com.cn
Sansure Biotech Inc is engaged in production and sales of diagnostic reagents and instruments. The company produces Class I medical devices, Class II medical devices, Class III medical devices, general instruments and meters, medical raw materials, medical laboratory equipment and appliances, and medical accessories.

Sansure Biotech (SHSE:688289) Headlines

No Headlines